---
figid: PMC9639785__fphar-13-979300-g009
pmcid: PMC9639785
image_filename: fphar-13-979300-g009.jpg
figure_link: /pmc/articles/PMC9639785/figure/F9/
number: FIGURE 9
figure_title: ''
caption: Possible pathways of action of sulfasalazine in high glucose. The possible
  pathways of action of sulfasalazine on endothelial dysfunction induced by high glucose.
  AGE, advanced glycation endproduct; RAGE, the receptor for advanced glycation endproduct;
  ROS, reactive oxygen speices; MAPK, the mitogen-activating protein kinase; eNOS,
  endothelial nitric oxide synthase; NO, nitric oxide; ERK, extracellular signal-regulated
  kinase; JNK, Janus kinase family; Nrf2, nuclear factor erythroid 2-related factor
  2; Nf-kB, nuclear factor “kappa-light-chain-enhancer” of activated B-cells; HO-1,
  Heme oxygenase; U0126, ERK inhibitor; SP600125, JNK inhibitor (Prepared on 11.06.2018
  using the website http://www.genome.jp/kegg/pathway.html).
article_title: Effect of sulfasalazine on endothelium-dependent vascular response
  by the activation of Nrf2 signalling pathway.
citation: Muhammed Ikbal Sonmez, et al. Front Pharmacol. 2022;13:979300.
year: '2022'

doi: 10.3389/fphar.2022.979300
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.

keywords:
- diabetes mellitus
- sulfasalazine
- Nrf2
- ERK
- rat aorta

---
